Celiac disease and COVID-19 in adults: A systematic review.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
10
02
2023
accepted:
03
05
2023
medline:
18
5
2023
pubmed:
16
5
2023
entrez:
16
5
2023
Statut:
epublish
Résumé
Celiac disease (CD) is an autoimmune disease affecting around 1.4% of the total human population. Local and systemic manifestations are described in CD. Viral infections seem to trigger CD or even have a worse outcome in CD patients. The evidence on the relationship between CD and coronavirus disease (COVID-19) is limited. To evaluate existing evidence on the association between CD and COVID-19, we conducted the current systematic review. We systematically searched Pubmed, Scopus, and Embase databases to find articles that reported risks or outcomes of COVID-19 in CD patients. Papers in any language published up to November 17, 2022, were evaluated for possible inclusion. The results were analyzed qualitatively. This study is registered with PROSPERO(CRD42022327380). We identified 509 studies by searching databases; 14 reported data on the risk or outcome of COVID-19 in CD patients and were eligible for qualitative synthesis. We found that the relative risk of acquiring COVID-19 in CD patients may be lower than in the general population. Approximately 90% of infected patients were treated as an outpatient, and 10% were hospitalized. GFD adherence and Health-related quality of life (HR-QOL) were more or less the same before and during the pandemic. The gluten-free products (GFP) supply seems to be plunged during the pandemic. The data on the psychological effects of the pandemic were conflicting. The risk of acquiring COVID-19 in CD patients is lower than in the general population. Females were more likely to be infected by COVID-19, and the most common comorbidity in infected patients was a chronic lower respiratory disease; around 10% of infected patients needed hospitalization, GFD adherence, and HR-QOL was more or less the same before and during the pandemic, depression, anxiety, and stress levels of patients varied among studies. Patients had more difficulties accessing GFPs based on limited data.
Sections du résumé
BACKGROUND
Celiac disease (CD) is an autoimmune disease affecting around 1.4% of the total human population. Local and systemic manifestations are described in CD. Viral infections seem to trigger CD or even have a worse outcome in CD patients. The evidence on the relationship between CD and coronavirus disease (COVID-19) is limited. To evaluate existing evidence on the association between CD and COVID-19, we conducted the current systematic review.
METHODS
We systematically searched Pubmed, Scopus, and Embase databases to find articles that reported risks or outcomes of COVID-19 in CD patients. Papers in any language published up to November 17, 2022, were evaluated for possible inclusion. The results were analyzed qualitatively. This study is registered with PROSPERO(CRD42022327380).
RESULTS
We identified 509 studies by searching databases; 14 reported data on the risk or outcome of COVID-19 in CD patients and were eligible for qualitative synthesis. We found that the relative risk of acquiring COVID-19 in CD patients may be lower than in the general population. Approximately 90% of infected patients were treated as an outpatient, and 10% were hospitalized. GFD adherence and Health-related quality of life (HR-QOL) were more or less the same before and during the pandemic. The gluten-free products (GFP) supply seems to be plunged during the pandemic. The data on the psychological effects of the pandemic were conflicting.
CONCLUSION
The risk of acquiring COVID-19 in CD patients is lower than in the general population. Females were more likely to be infected by COVID-19, and the most common comorbidity in infected patients was a chronic lower respiratory disease; around 10% of infected patients needed hospitalization, GFD adherence, and HR-QOL was more or less the same before and during the pandemic, depression, anxiety, and stress levels of patients varied among studies. Patients had more difficulties accessing GFPs based on limited data.
Identifiants
pubmed: 37192180
doi: 10.1371/journal.pone.0285880
pii: PONE-D-23-03782
pmc: PMC10187909
doi:
Types de publication
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0285880Informations de copyright
Copyright: © 2023 Amirian et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Clin Transl Gastroenterol. 2022 May 01;13(5):e00480
pubmed: 35347089
Am J Gastroenterol. 2020 Apr;115(4):507-525
pubmed: 32022718
Int J Environ Res Public Health. 2021 Sep 27;18(19):
pubmed: 34639443
Ann Med. 2022 Dec;54(1):617-621
pubmed: 35175152
Front Nutr. 2020 Feb 07;7:6
pubmed: 32118025
HLA. 2021 Jul;98(1):14-22
pubmed: 33896121
Eur J Gastroenterol Hepatol. 2021 Nov 1;33(11):1361-1366
pubmed: 33399400
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1841-1845
pubmed: 32971511
Gastroenterology. 2021 Jan;160(1):63-75
pubmed: 32950520
Annu Rev Pathol. 2023 Jan 24;18:47-70
pubmed: 36067801
BMJ. 2021 Mar 29;372:n160
pubmed: 33781993
Infect Dis Poverty. 2020 May 29;9(1):58
pubmed: 32471513
Clin Epidemiol. 2021 Feb 18;13:121-130
pubmed: 33628059
Eur Rev Med Pharmacol Sci. 2021 Jun;25(12):4400-4404
pubmed: 34227075
Indian J Gastroenterol. 2021 Dec;40(6):613-620
pubmed: 34877633
World J Gastroenterol. 2021 Mar 28;27(12):1213-1225
pubmed: 33828395
Nutrients. 2021 May 09;13(5):
pubmed: 34065154
Gastroenterol Hepatol Bed Bench. 2022 Spring;15(2):153-157
pubmed: 35845298
Scand J Gastroenterol. 2023 Feb;58(2):142-147
pubmed: 36049123
Dig Liver Dis. 2022 Jan;54(1):3-9
pubmed: 34561158
J Psychosom Res. 2021 Dec;151:110652
pubmed: 34739942
Acta Gastroenterol Belg. 2020 Oct-Dec;83(4):517-525
pubmed: 33321006
Science. 2021 Feb 12;371(6530):741-745
pubmed: 33436525
Ann Gastroenterol. 2022 Mar-Apr;35(2):164-168
pubmed: 35479592
J Psychosom Res. 2022 Feb;153:110711
pubmed: 34999379
Front Immunol. 2021 Jan 08;11:601886
pubmed: 33488597
Clin Exp Med. 2020 Nov;20(4):493-506
pubmed: 32720223